X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (219) 219
male (187) 187
female (183) 183
index medicus (179) 179
middle aged (177) 177
aged (156) 156
oncology (154) 154
adult (149) 149
cancer (113) 113
chemotherapy (89) 89
metastasis (76) 76
treatment outcome (75) 75
retrospective studies (72) 72
prognosis (64) 64
aged, 80 and over (60) 60
survival (59) 59
antineoplastic combined chemotherapy protocols - therapeutic use (56) 56
medicine & public health (51) 51
care and treatment (48) 48
antineoplastic agents - therapeutic use (46) 46
disease-free survival (43) 43
carcinoma, renal cell - drug therapy (42) 42
survival analysis (42) 42
helicobacter pylori (41) 41
neoplasm metastasis (41) 41
sunitinib (41) 41
kidney neoplasms - drug therapy (38) 38
analysis (36) 36
microbiology (35) 35
pharmacology & pharmacy (35) 35
carcinoma, renal cell (33) 33
cancer research (32) 32
pharmacology/toxicology (32) 32
therapy (31) 31
young adult (31) 31
antineoplastic combined chemotherapy protocols - adverse effects (30) 30
drug administration schedule (30) 30
adolescent (29) 29
kidney neoplasms - pathology (29) 29
capecitabine (28) 28
carcinoma (28) 28
research (28) 28
tumors (28) 28
fluorouracil (27) 27
mutation (27) 27
risk factors (26) 26
kaplan-meier estimate (25) 25
trial (25) 25
antineoplastic agents - adverse effects (24) 24
biochemistry (24) 24
drug therapy (24) 24
renal cell carcinoma (24) 24
chemistry (23) 23
interferon-alpha (23) 23
medical colleges (23) 23
metallurgy (23) 23
neoplasm staging (23) 23
antineoplastic agents (22) 22
beer (22) 22
cisplatin (22) 22
enzymology (22) 22
follow-up studies (22) 22
mutation or genetic engineering (22) 22
spirits (22) 22
vinegar (22) 22
wine (22) 22
deoxycytidine - analogs & derivatives (21) 21
stomach neoplasms - drug therapy (21) 21
5-fluorouracil (20) 20
antimitotic agents (20) 20
efficacy (20) 20
prospective studies (20) 20
sorafenib (20) 20
surgery (20) 20
leucovorin (19) 19
metastases (19) 19
patients (19) 19
proportional hazards models (19) 19
survival rate (19) 19
time factors (19) 19
vascular endothelial growth factor (19) 19
adenocarcinoma - drug therapy (18) 18
antineoplastic agents - administration & dosage (18) 18
carcinoma, renal cell - mortality (18) 18
colorectal cancer (18) 18
colorectal neoplasms - drug therapy (18) 18
compositions or test papers therefor (18) 18
condition-responsive control in microbiological orenzymological processes (18) 18
disease progression (18) 18
expression (18) 18
fluorouracil - administration & dosage (18) 18
hematology, oncology and palliative medicine (18) 18
kidney neoplasms - mortality (18) 18
measuring or testing processes involving enzymes, nucleicacids or microorganisms (18) 18
medicine, general & internal (18) 18
multivariate analysis (18) 18
oxaliplatin (18) 18
processes of preparing such compositions (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
carcinoma, renal cell - pathology (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 369 - 369
Journal Article
Scientific reports, ISSN 2045-2322, 06/2019, Volume 9, Issue 1, pp. 8305 - 7
This retrospective study compared adjuvant chemotherapy (AC) versus observation after radical cystectomy (RC) in patients with node-positive bladder cancer... 
Chemotherapy | Health risk assessment | Bladder cancer | Survival | Lymph nodes | Cancer
Journal Article
by Park, K and Baek, Y and Lee, JL
ANTICANCER RESEARCH, ISSN 0250-7005, 07/2019, Volume 39, Issue 7, pp. 3937 - 3944
Background: The study aim was to evaluate the efficacy of wrapping oblate for prevention of everolimus-associated stomatitis in metastatic renal cell carcinoma... 
MAMMALIAN TARGET | RAPAMYCIN | everolimus | stomatitis | MANAGEMENT | EFFICACY | ONCOLOGY | Renal cell carcinoma | TYROSINE KINASE | oblate | PHASE-2 | INHIBITORS | Tyrosine | Metastasis | Kinases | Crossovers | Incidence | Metastases | Prevention | Stomatitis | Kidney cancer | Vascular endothelial growth factor | Protein-tyrosine kinase | Growth factors | Clear cell-type renal cell carcinoma
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 616 - 616
Journal Article
Laboratory Investigation, ISSN 0023-6837, 05/2019, Volume 99, Issue 5, pp. 659 - 670
Journal Article
Investigational New Drugs, ISSN 0167-6997, 2019, pp. 1 - 8
Introduction We conducted a multicenter, phase 2 trial using gemcitabine plus axitinib (GX) in patients with recurrent or metastatic sarcomatoid renal cell... 
Axitinib | Chemotherapy | Sarcomatoid | Gemcitabine | Renal cell carcinoma | Hypertension | Medical research | Anorexia | Toxicity | Clinical trials | Histology | Disease control | Patients | Metastases | Biopsy | Kidney cancer | Solid tumors | Clear cell-type renal cell carcinoma | Tumors | Neutropenia
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 07/2019, Volume 104, Issue 4, pp. 819 - 827
We assessed the efficacy of adjuvant treatments in patients with peripelvic/periureteral fat-infiltrating (pT3b), nonmetastatic upper tract urothelial... 
RADICAL NEPHROURETERECTOMY | SURVIVAL | BLADDER-CANCER | RENAL PELVIS | ONCOLOGY | TRANSITIONAL-CELL CARCINOMA | LYMPHOVASCULAR INVASION | RADIOTHERAPY | OUTCOMES | EUROPEAN ASSOCIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Care and treatment | Carcinoma | Analysis | Radiation | Adjuvant treatment | Metastasis | Radiotherapy | Cancer
Journal Article
Clinical Genitourinary Cancer, ISSN 1558-7673, 09/2019
Journal Article
Journal Article
Pathology & Oncology Research, ISSN 1219-4956, 1/2019, Volume 25, Issue 1, pp. 51 - 58
Vascular endothelial growth factor receptor (VEGFR)-targeted therapy improved the outcome of metastatic renal cell carcinoma (mRCC) patients. However, a... 
Biomedicine, general | Metastatic renal cell carcinoma | Pathology | Response classifier | Biomedicine | Immunology | Vascular endothelial growth factor signaling | Machine learning | Cancer Research | Oncology | Tyrosine kinase inhibitors | TARGETED THERAPY | BIOMARKERS | PROGNOSTIC-FACTORS | ONCOLOGY | SUNITINIB | PATHOLOGY | Kidney Neoplasms - genetics | Prognosis | Follow-Up Studies | Carcinoma, Renal Cell - pathology | Humans | Carcinoma, Renal Cell - genetics | Survival Rate | Case-Control Studies | Protein Kinase Inhibitors - therapeutic use | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Kidney Neoplasms - pathology | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Retrospective Studies | Gene Expression Regulation, Neoplastic - drug effects | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Classifiers | Medical services | Metastasis | Lymph nodes | Necrosis | Metastases | Proteins | Gangrene | Thrombocytosis | Decision trees | Vascular endothelial growth factor | Growth factors | Protein-tyrosine kinase | Fibroblast growth factor receptor 2 | Interleukin 8 | Tyrosine | Medical treatment | MiRNA | Gene expression | Patients | Vascular endothelial growth factor receptors | Support vector machines | Inhibitors | PD-L1 protein | Kidney cancer | Mutation | Clear cell-type renal cell carcinoma
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.